ARYEH JASON sold 12.6% of their position (10K shares) of LIGAND PHARMACEUTICALS INC on the open market
Open‑market sale worth $1.71M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 9/24/2025ACC: 0002001011-25-000082
-10K
Net shares
Net seller
$1.71M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
10K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−4.42K
Price / share
$170.41
Trade value
$752.85K
% of position
5.6%
9/23/2025
79.29K→74.87K
Common Stock
Direct
Shares
−4.63K
Price / share
$170.96
Trade value
$791.22K
% of position
6.2%
9/23/2025
74.87K→70.24K
Common Stock
Direct
Shares
−954.00
Price / share
$171.92
Trade value
$164.02K
% of position
1.4%
9/23/2025
70.24K→69.29K
Total
Net shares
−10K
Net value
-$1.71M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/23/2025 | S · Sale | −4.42K | $170.41 | $752.85K | 5.6% | 79.29K | 74.87K |
| Common Stock Direct | 9/23/2025 | S · Sale | −4.63K | $170.96 | $791.22K | 6.2% | 74.87K | 70.24K |
| Common Stock Direct | 9/23/2025 | S · Sale | −954.00 | $171.92 | $164.02K | 1.4% | 70.24K | 69.29K |
| Total | −10K | -$1.71M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned51.59K
Common Stock
IndirectShares owned5.03K
Total
56.62K indirect56.62K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 51.59K | Indirect |
| Common Stock | 5.03K | Indirect |
| Total | 56.62K | 56.62K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported